Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.gov public full text Public Domain

Prospective Study for the Use of Palivizumab (Synagis®) in High-risk Children in Germany

AbbVie (prior sponsor, Abbott) · 2002
ClinicalTrials.gov · Datasets · License: Public Domain · 2002
Open Source ↗
childrencongenital-heart-diseaseinfectionrespiratory-syncytial-virusrespiratory-syncytial-virus-infections
The SYNAGIS Registry was carried out in order to gather comprehensive real-world data on the use of palivizumab in children at high risk for serious respiratory syncytial virus (RSV) disease. This registry was designed as a post-marketing observational study, and conducted with the aim of collecting data on palivizumab administration, the risk factors for complicated RSV disease, frequency of hospitalizations, and drug adherence.
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1371788
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive